Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) just unveiled an update.
Zylox-Tonbridge Medical Technology Co., Ltd. has announced an upcoming board meeting scheduled for April 25, 2025. The meeting will address the recommendation for the payment of a final dividend for the year ending December 31, 2024, among other business matters, potentially impacting shareholder returns and company financial strategies.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the medical technology industry. The company is listed on the Hong Kong Stock Exchange and focuses on developing and providing advanced medical devices.
YTD Price Performance: 29.23%
Average Trading Volume: 141
Technical Sentiment Signal: Strong Sell
Current Market Cap: €580.8M
See more data about 2190 stock on TipRanks’ Stock Analysis page.